Narrow search
Showing 1 - 10 of 108
Cover Image
Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals
Dubois, Pierre; Lasio, Laura - C.E.P.R. Discussion Papers - 2014
chosen in some markets, for example due to regulation. We use our identification strategy to study the effects of regulatory …-ulcer drugs that allows us to explore the drivers of demand, to identify whether regulation in France truly affects margins and … increased over the 2004-2007 period because of new regulation of price setting that reduced branded drugs prices but increased …
Persistent link: https://www.econbiz.de/10011083879
Cover Image
Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?
de Frutos, Maria-Angeles; Ornaghi, Carmine; Siotis, Georges - C.E.P.R. Discussion Papers - 2010
We present a Hotelling model of price and advertising competition between prescription drugs that differ in quality/side e¤ects. Advertising results in the endogenous formation of two consumer groups: brand loyal and non-brand loyal ones. We show that advertising strategies are strategic...
Persistent link: https://www.econbiz.de/10008680762
Cover Image
Does Europe have an innovation policy? The case of EU economic law
Battaglia, Lauren; Larouche, Pierre; Negrinotti, Matteo - C.E.P.R. Discussion Papers - 2011
innovation policy in the context of EU economic law (competition policy, intellectual property law, sector regulation). As such … pharmaceuticals, specifically drug reformulation regulatory gaming. …
Persistent link: https://www.econbiz.de/10009205060
Cover Image
Investments in Pharmaceuticals Before and After TRIPS
Kyle, Margaret K; McGahan, Anita M - C.E.P.R. Discussion Papers - 2011
This paper addresses the relationship between patent protection and investment in the development of new pharmaceutical treatments. The TRIPS Agreement, which specifies minimum levels of intellectual property protection for countries in the World Trade Organization, has increased levels of...
Persistent link: https://www.econbiz.de/10009002387
Cover Image
Market Size and Pharmaceutical Innovation
de Mouzon, Oliver; Dubois, Pierre; Scott Morton, Fiona; … - C.E.P.R. Discussion Papers - 2011
the hypothesis that innovation in pharmaceuticals is becoming more difficult and expensive over time, as costs of …
Persistent link: https://www.econbiz.de/10009003149
Cover Image
Pharmaceuticals - Who's Afraid of `1992'?
Klepper, Gernot - C.E.P.R. Discussion Papers - 1992
creating an internal market for pharmaceuticals can be analysed. In a model of third-degree price discrimination, arbitrage … Market in pharmaceuticals are ambiguous, since a movement from segmented and price-controlled markets towards integrated …
Persistent link: https://www.econbiz.de/10005114350
Cover Image
Vaccines vs. Preventives
Kremer, Michael; Snyder, Christopher - C.E.P.R. Discussion Papers - 2015
Preventives are sold ex ante, before disease status is realized, while treatments are sold ex post. Even if the mean of the ex ante distribution of consumer values is the same as that ex post, the shape of the distributions may differ, generating a difference between the surplus each product can...
Persistent link: https://www.econbiz.de/10011196028
Cover Image
Parallel Imports and Price Controls
Grossman, Gene; Lai, Edwin - C.E.P.R. Discussion Papers - 2006
pharmaceuticals. We challenge this orthodox view and show, to the contrary, that the pace of innovation often is faster in a world …
Persistent link: https://www.econbiz.de/10005666872
Cover Image
Effect of Regulatory Constraints on Fund Performance: New Evidence from UCITS Hedge Funds
Joenväärä, Juha; Kosowski, Robert - C.E.P.R. Discussion Papers - 2015
We economically motivate and then test a range of hypotheses regarding performance and risk differences between UCITS-compliant and other hedge funds. The latter exhibit more suspicious return patterns than do absolute return UCITS (ARUs), but ARUs exhibit higher levels of operational risk. We...
Persistent link: https://www.econbiz.de/10011272713
Cover Image
Investment and capital structure of partially private regulated firms
Cambini, Carlo; Spiegel, Yossi - C.E.P.R. Discussion Papers - 2011
We develop a model that examines the capital structure and investment decisions of regulated firms in a setting that incorporates two key institutional features of the public utilities sector in many countries: firms are partially owned by the state and regulators are not necessarily...
Persistent link: https://www.econbiz.de/10009209829